Akseli Hemminki

Biography

Following an award-winning PhD in cancer genetics, Dr Hemminki completed his MD and then moved to the US to learn about gene therapy in 2000. He fell in love with oncolytic viruses and helped set up three clinical trials at the University of Alabama at Birmingham. Subsequent to returning to Finland he specialized in oncology and radiotherapy and set up his research group, the Cancer Gene Therapy Group, at the University of Helsinki. He has won numerous awards, including the Best PhD thesis in the Faculty, the Sigrid Juselius Award, the Duodecim Young Researcher award and the EACR Young European Cancer Researcher Award.

Research Interest

Pharmaceutical Sciences